Type 2 diabetes and cancer: problems and suggestions for best patient management

• Main Authors: Agostino Milluzzo (Author), Paolo Vigneri (Author), Federica Martorana (Author), Riccardo Vigneri (Author), Laura Sciacca (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.37349/emed.2020.00013; 2692-3106
• Keywords: diabetes; cancer; glycaemic target; oral hypoglycaemic agents; anticancer therapy; chronic complications; Other systems of medicine; RZ201-999
• Source: Exploration of Medicine, Vol 1, Iss 4, Pp 184-204 (2020)

Diabetes and cancer are widespread worldwide and the number of subjects presenting both diseases increased over the years. The management of cancer patients having diabetes represents a challenge not only because of the complexity and heterogeneity of these pathologies but also for the lack of standardised clinical guidelines. The diagnosis of cancer is traumatizing and monopolizes the attention of both patients and caregivers. Thus, pre-existent or new-onset diabetes can be overshadowed thus increasing the risk for short- and long-term adverse events. Moreover, drugs used for each disease can interfere with the clinical course of the concomitant disease, making challenging the management of these patients. Over the years, this issue has become more relevant because of the increased patients' life expectancy due to the improved efficacy of diabetes and cancer therapies. The purpose of this review is to highlight what is known and what should be taken into consideration to optimise the clinical management of patients with diabetes and cancer. Due to the complexity of these diseases, a multidisciplinary, shared approach, including all the protagonists involved, is necessary to improve patients' quality of life and lifespan.